Skip to main content
No.1 Press Release Service in Korea
Search
Search
Login
Create Account
Services
Contact Us
News
Services
About Us
Contact Us
Korean
News
All News
News by Region
Korea
Overseas
News by Industry
Agriculture
Automobiles
Business
Construction/Realestate
Culture/Entertainment
Education
Energy/Environment
Finance
Health
Heavy Industries
Life Style
Media
Policy/Government
Retail
Society
Sports
Technology
Transportation
Travel
Services
Why Korea Newswire?
How We Distribute
Services & Pricing
Basic
Standard
Premium
Global
Translation
Press Release Network in Korea
Korean Language
About Us
News
Services
Contact Us
Search
Cancel
Search
Submit Press Release
Latest News
News by Region
Korea
World
News by Industry
Agriculture
Automobiles
Business
Construction / Realestate
Culture / Entertainment
Education
Energy / Environment
Finance
Health
Heavy Industries
Life Style
Media
Policy / Government
Retail
Society
Sports
Technology
Transportation
Travel
Health News Releases
Today March 21
October 25, 2022 10:30
Biotechs, Developing Countries Vaccine Manufacturers and Pharma Unite Behind a Proposal to G20 and G7 Offering a Practical Solution for Better Access to Vaccines for Future Pandemics
The Biotechnology Innovation Organization (BIO), Developing Countries Vaccine Manufacturers’ Network (DCVMN) and the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) h
October 24, 2022 18:00
GQC Is Born: the First Start-up, Federated by PQE Group, to Support Medical Cannabis
The world's first start-up to support pharmaceutical companies in every aspect of medical cannabis development and distribution is Italian. Named GQC - Glocal Quality Cannabis, it is one of the federa
October 21, 2022 11:10
LEO Pharma Announces European Commission Approval of Adtralza® (tralokinumab) for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents
NOT FOR DISTRIBUTION IN THE UK OR IRELAND LEO Pharma A/S, a global leader in medical dermatology, today announced that the European Commission (EC) has extended the marketing authorization for Adtr
October 21, 2022 11:00
Ferring Presents New Subgroup Analyses of Health-Related Quality of Life and Safety and Efficacy Data at IDWeek 2022 for RBX2660, Its Investigational Microbiota-based Live Biotherapeutic
Ferring Pharmaceuticals today announced the presentation of two subgroup analyses at Infectious Disease Week (IDWeek) 2022 that further characterize RBX2660, an investigational microbiota-based live b
October 21, 2022 10:40
University of Tübingen and Boehringer Ingelheim Join Forces to Lead AI and Data Science R&D for New Medical Breakthroughs
University of Tübingen, a leading member of Cyber Valley, Europe’s largest Artificial Intelligence (AI) research consortium and Boehringer Ingelheim launch an AI and data science fellowship program fo
October 21, 2022 10:33
Takeda Enters Collaboration and Licensing Agreement with Zedira and Dr. Falk Pharma to Develop First-in-Class Celiac Disease Therapy
Takeda (TSE:4502/NYSE:TAK), Zedira and Dr. Falk Pharma GmbH today announced a collaboration and licensing agreement to develop ZED1227/TAK-227, a Phase 2b investigational therapy for the treatment of
October 20, 2022 16:25
Approval of extension of exemptions from SIX disclosure and publicity obligations
Regulatory News: AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Vifor Pharma AG (Vifor) announced today that by decision dated October 19, 2022, SIX Exchange Regulation AG (SER) has approved an exte
October 19, 2022 17:00
Global Excel Management Announces Strategic Partnership With Flightcare Global
Global Excel Management Inc. (Global Excel), a leading supplier of global healthcare risk management solutions, is pleased to announce that it has acquired a majority ownership in Blue Sky Health Pty
October 19, 2022 11:50
Lysando AG and Amicogen Inc. Sign General Development Agreement
Lysando AG - market leader in the field of antimicrobial proteins - has signed a general development agreement with Amicogen Inc., a publicly traded biotechnology company and CDMO headquartered in Sou
October 18, 2022 17:30
Eucure Biopharma, a Subsidiary of Biocytogen Pharmaceuticals, Licenses OX40 Antibody (YH002) and Multiple Active Ingredients to Syncromune for the Development and Commercialization of Intratumoral Immunotherapy
Eucure (Beijing) Biopharma Co., Ltd. (“Eucure”), a wholly owned subsidiary of Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”), announced today that the company has entered into a worldwi
October 18, 2022 11:50
Single Use Support Launches IRIS Single-Use Bag Line
Austrian solution provider Single Use Support GmbH is expanding its product portfolio with new single-use bioprocess containers under the brand name IRIS. The pioneering company leverages its know-how
October 18, 2022 10:30
ESAB Corporation Acquires Ohio Medical
ESAB Corporation (“ESAB” or the “Company”) (NYSE: ESAB), a world leader in fabrication and gas control technology, announced today that it has acquired Ohio Medical, LLC (“Ohio Medical”), a global lea
October 17, 2022 11:35
CHMP recommends conditional marketing authorization for Spesolimab as first in class treatment option for generalized pustular psoriasis flares
The European Medicine Agency’s Committee for Medicinal Products for Human Use (CHMP) recommended the granting of a conditional market authorization[*] for Boehringer Ingelheim’s spesolimab as first in
October 17, 2022 11:30
Takeda Receives Positive CHMP Opinion Recommending Approval of Dengue Vaccine Candidate in EU and Dengue-Endemic Countries
Takeda (TSE:4502/NYSE:TAK) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommended the approval of Takeda’s dengue vaccine can
October 14, 2022 10:20
Wyss Center for Bio and Neuroengineering: New Horizons in Neural Recording Systems
A new whitepaper, released by the Wyss Center for Bio and Neuroengineering, reveals the first neural signals recorded by the ABILITY brain-computer interface (BCI) system. It also lays out the plan fo
October 14, 2022 09:35
GE Healthcare Announces Multi-Year Agreement with SQM to Secure Iodine Supply for Contrast Media
GE Healthcare’s Pharmaceutical Diagnostics business has announced a long-term agreement with Chile-based mining company, Sociedad Quimica y Minera de Chile S.A. (SQM) (NYSE: SQM; Santiago Stock Exchan
October 13, 2022 16:30
Galderma Announces Intention to Expand Manufacturing and Innovation Footprint in Asia-Pacific
Reaffirming its bold ambition to become the leading dermatology company in the world, Galderma today announced its intention to expand its manufacturing and innovation footprint in the Asia-Pacific re
October 13, 2022 13:30
Trueman Man Clinic Network Demonstrates Its Excellence in Gynecomastia Surgery in Korea with 25,700 Operations
Trueman Man Clinic Network announced that it has performed more than 25,700 gynecomastia operations as of September 2022 from 2010. Trueman Man Clinic Network is a renowned hospital for male-specific
October 12, 2022 17:20
Approval of delisting of Vifor Pharma AG's registered shares
Regulatory News: AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Vifor Pharma AG (SWX:VIFN) (Vifor) announced today that Vifor has received approval for the delisting of the totality of Vifor's regis
October 12, 2022 17:10
Sermo Surveys Reveals 87% of Global Physicians Feel There is a Lack of Clinical Guidelines on How to Treat Long Covid in Patients
A new survey from Sermo, a physician-first online community and leader in global HCP insights, found that the majority of physicians feel there is a lack of clinical guidelines to diagnose and treat L
October 11, 2022 11:35
DENTALIS Animal Health Develops Products to Improve the Oral Health of Companion Animals
Animal health veterans and human dental experts have combined and formed a start-up company dedicated to the development of superior oral health care products for companion animals, currently developi
October 07, 2022 16:28
ProDERM Study Results of octagam® 10% Treatment in Patients With Dermatomyositis Published in the New England Journal of Medicine
Octapharma announced today the results from the ProDERM study on the efficacy and safety of octagam® 10% [Immune Globulin Intravenous (Human)], in adult dermatomyositis (DM) patients have been publish
October 06, 2022 21:00
Aleph Farms Expands Global Leadership Team with Key Appointment and New Office in the United States
Aleph Farms, the first cultivated meat company to grow steaks directly from non-genetically engineered animal cells, today announced the addition of Kevin Benmoussa as its Executive VP and Chief Finan
October 05, 2022 17:15
Last-mile veterinary delivery social start-up Cowtribe first investment of Boehringer Ingelheim Social Engagements
Boehringer Ingelheim announced today that Cowtribe is the first recipient of investment and non-financial support from the Boehringer Ingelheim Social Engagement (BI SE) initiative, a program which ai
October 05, 2022 14:30
Frazier Life Sciences Adds Experienced Biopharmaceutical Executive to Team
Frazier Life Sciences announced the addition of Jan Møller Mikkelsen as a Senior Advisor. He has over 30 years of experience as a biopharmaceutical executive. Mr. Mikkelsen founded Ascendis Pharma
October 04, 2022 16:42
DentalMonitoring Expands into Japan
New office in Tokyo; bringing smarter dentistry solutions to Japan. DentalMonitoring, the leading global provider of smart dentistry solutions, is setting foot in Japan to serve the Asian market wi
October 04, 2022 15:30
Autologous immune-cell therapy, practiced in Japan, now helping Vinmec Hospital, treat cancer patients in Hanoi, Vietnam, after technology transfer by GN Corporation
Treatment of cancer using one’s own immune cells, natural killer (NK) cells and T-cells, called autologous immune enhancement cell therapy (AIET) administered along with conventional chemotherapy, rad
October 04, 2022 11:40
The Estée Lauder Companies Launches 2022 Breast Cancer Campaign to Honor 30th Anniversary and Positively Impact the Global Breast Cancer Community
In the 30 years since Evelyn H. Lauder launched The Estée Lauder Companies’ Breast Cancer Campaign (The Campaign) and co-created the Pink Ribbon in 1992, The Campaign’s mission to help create a breast
September 30, 2022 10:30
Burjeel Holdings Lights Up Burj Khalifa With New Campaign Featuring Shah Rukh Khan
A month ahead of his birthday, Indian actor Shah Rukh Khan lit up the world’s tallest building, The Burj Khalifa, on Wednesday evening, in a brand campaign for the UAE-based conglomerate Burjeel Holdi
September 30, 2022 09:10
Monrol Will Establish a Legal Entity and Manufacturing Facility in Germany
Following an ongoing assessment of its entire operation, Eczacıbaşı-Monrol Nuclear Products Co. (Monrol) has decided to establish a legal entity and manufacturing facility in Germany. The new facil
September 29, 2022 13:43
Johnson & Johnson Announces Kenvue as the Name for Planned New Consumer Health Company
Johnson & Johnson (the “Company”) (NYSE: JNJ) today took another step forward in establishing two independent, market-leading companies with the announcement of Kenvue as the name for the planned New
September 28, 2022 17:10
Biocytogen to Present at BioJapan2022, Introducing Innovative R&D Platforms, Bispecific ADC Programs and Pipeline Progress
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315) will host a seminar at the BioJapan2022 Conference on Friday, October 14. The seminar, consisting of 3 modules, will introduc
September 28, 2022 16:34
Olympus Launches THUNDERBEAT Energy Device for Open Surgery
Olympus Corporation (Olympus), a global medtech company committed to making people's lives healthier, safer, and more fulfilling, today announced the release of the THUNDERBEAT(TM) Open Fine Jaw Type
September 27, 2022 17:40
New Survey from Philip Morris International Reveals Strong Societal Support for Disruptive Innovations to Drive Public Health Progress
A new international survey released today by Philip Morris International Inc. (PMI) (NYSE: PM) reveals that despite broad public support for disruptive innovation to address global challenges, issues
September 27, 2022 17:15
Covetrus Names Michelle Bonfilio as Chief People Officer
Covetrus® (NASDAQ: CVET), a global leader in animal-health technology and services, today announced the appointment of Michelle Bonfilio as Chief People Officer, reporting to Ben Wolin, President and
September 23, 2022 13:30
Ferring Receives Positive Vote from U.S. FDA Advisory Committee for RBX2660
Ferring Pharmaceuticals today announced that the Vaccines and Related Biological Products Advisory Committee (VRBPAC) of the U.S. Food and Drug Administration (FDA) issued a positive vote for RBX2660,
September 22, 2022 15:00
Merck Enters Collaboration and Option to License Agreement with Nerviano Medical Sciences to Develop Next-Generation PARP1 Selective Inhibitor
Merck, a leading science and technology company, today announced a collaboration agreement with licensing option with Nerviano Medical Sciences S.r.l. (NMS) for the next-generation highly selective an
September 22, 2022 14:35
Nerviano Medical Sciences S.r.l. Announces Collaboration and Option to License Agreement with Merck
Nerviano Medical Sciences S.r.l. (NMS), a member of the NMS Group and a clinical stage company discovering and developing innovative therapies for the treatment of cancer, announced today the signing
September 20, 2022 17:20
Galderma Debuts The Sensitive Skincare Faculty, a Global Expert Group to Improve Understanding and Management of Sensitive Skin
Reinforcing its commitment to advancing dermatology for every skin story, Galderma announced today the formation of a global Sensitive Skincare Faculty, which will focus its efforts on helping people
September 20, 2022 10:30
Takeda Signs Virtual Power Purchase Agreement with Enel North America to Advance Renewable Energy Production in the United States
Takeda (TSE:4502/NYSE:TAK) and Enel North America today announced the signing of a long-term virtual power purchase agreement (VPPA) for the electricity delivered to the power grid from a 79 megawatt
September 19, 2022 14:10
LEO Pharma Receives Positive CHMP Opinion of Adtralza® (tralokinumab) for the Treatment of Adolescents With Moderate-to-Severe Atopic Dermatitis
LEO Pharma A/S, a global leader in medical dermatology, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opi
September 19, 2022 10:30
Takeda Receives Positive CHMP Opinion for Maribavir for the Treatment of Adults with Post-transplant Cytomegalovirus (CMV) Refractory (With or Without Resistance) to Prior Therapies
Takeda (TSE:4502/NYSE:TAK) today announced the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of maribavir for the treatment of cy
September 19, 2022 09:40
Olympus Launches VISERA ELITE III Surgical Visualization Platform
Olympus Corporation (“Olympus” - Director, Representative Executive Officer, President and CEO: Yasuo Takeuchi) today announced the launch of VISERA ELITE III, its newest surgical visualization platfo
September 16, 2022 15:40
Hyperice Brings the Heat With Introduction of All-New Venom Go and Venom 2
Hyperice, a global high-performance wellness brand, today announced two new products within their heat therapy category, Venom Go and Venom 2, alongside HyperHeat™ technology for the fastest, most con
September 16, 2022 11:55
DentalMonitoring Launches DM Insights
DM Insights joins the DM Intelligent Platform, DentalMonitoring’s full suite of solutions designed to improve the quality of care and the patient experience while growing practices at the same time. M
September 16, 2022 11:20
UAE’s Burjeel Medical City Successfully Carries Out Its First Kidney Transplant
Providing an option for local and international patients to undergo kidney transplantation in private hospitals in the UAE’s Abu Dhabi, Burjeel Medical City (BMC) has started performing kidney transpl
September 15, 2022 15:30
Biocytogen Announces Collaboration with FineImmune to Develop TCR-Mimic Antibody-based Cell Therapy
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315) announced a strategic collaboration with Guangzhou FineImmune Biotechnology Co., LTD. (“FineImmune”) to co-develop cell-based
September 15, 2022 14:00
Prolific Machines Raises $42M From Top Planetary Health Investors to Build the Assembly Line for Biology
Prolific Machines, a next generation biotechnology company, is emerging from stealth today by announcing their massively oversubscribed Seed and Series A financings, led by the best VCs in the space.
September 14, 2022 17:30
Takeda Selects New Partners for Global Corporate Social Responsibility (CSR) Program to Strengthen Health Systems in Low- and Middle-Income Countries
Takeda (TSE:4502/NYSE:TAK) today announced four new partnerships to its Global Corporate Social Responsibility (CSR) Program, which makes long-term commitments to strengthen healthcare for people in d
September 14, 2022 16:00
VeriSilicon Announces the One-Stop VeriHealth Chip Design Platform for Smart Healthcare Applications
VeriSilicon (688521.SH), a leading Silicon Platform as a Service (SiPaaS®) company, today announced the launch of its customizable one-stop health chip design platform-VeriHealth™. Based on VeriSilico
«
2
3
4
5
6
»
50 per page
25 per page
50 per page
75 per page
100 per page
Distribute Your News to
KOREA
The largest press release distribution network in Korea
34,000 journalists
7,000 media outlets
345 industry channel
74,000 subscribers
Get Started
Global PR service
Reach Your Target
Audience in 162 Countries
powered by
Get Started
News by region
Korea
Overseas
News by industry
Agriculture
Automobiles
Business
Construction / Realestate
Culture / Entertainment
Education
Energy / Environment
Finance
Health
Heavy Industries
Life Style
Media
Policy / Government
Retail
Society
Sports
Technology
Transportation
Travel
Notice